Motion Informatics Ltd

As CEO of Motion Informatics Ltd, I have the privilege of guiding a visionary company that's redefining the landscape of neuromuscular rehabilitation. Our commitment to innovation is exemplified by our relentless pursuit of technological breakthroughs that empower patients and redefine the healing process. With this ethos, we launched Stimel-03, a product that has already begun transforming patient outcomes with its FDA-cleared BioRhythmIQ Technology. Gaining traction in markets across the USA and Southeast Asia, Stimel-03 is a testament to the scalability and efficacy of our solutions and the robustness of our business model, which encompasses SaaS, direct sales, electrode sales, and device sales.

This foundation sets the stage for Stimel-AR, our most ambitious endeavor yet. As our forthcoming flagship offering, Stimel-AR embodies our mission to merge the latest spatial technology with Functional and Neuromuscular Electrical Stimulation to create a deeply immersive and adaptive therapeutic experience. It's more than a product; it's a gateway to a new era of personalized and engaging rehabilitation that aligns with the everyday lives and challenges of our patients.

Our journey thus far has proven that at Motion Informatics, we don't just follow trends—we set them. With the upcoming launch of Stimel-AR, we are not just poised for growth; we are paving the way for a future where technology and patient care converge to deliver unmatched rehabilitation experiences globally. Join us as we continue to innovate and lead in a sector that improves lives and paves the way for a brighter, healthier future.

Chief Executive Officer

Federation of Asian Biotech Associations (FABA)

The Federation of Asian Biotech Associations (FABA), is a not-for-profit organization established in 2005 with a mission of providing a global platform for Academy, Industry, and Government bodies to come together, interact, and discuss the issues of common interest for improving the biotech space, including technology transfer, resource-sharing, business collaborations, Industry-Academia linkages, cross-border trade and investments, etc. among its member countries. BioAsia has been the flagship event of FABA, which is being organized in Hyderabad annually for the past 16 years. Over the years BioAsia has evolved as the most prestigious and widely attended Bio-business event in Asia. The event aims to enhance, encourage and enrich latest innovations, technologies and discoveries in the field of biotechnology. Also, it brings together the pharmaceutical industries and global biotechnology industries. The event aims at conducting seminars and sessions to enable industrialists get in contact with latest inventors displaying potentially successful devices and technologies that would help flourish the biotechnology industry worldwide. This has become a must attend event for all Pharma and Biotech companies, R&D departments all around the globe to network and enhance their standards.

Director of Israel

Synergen MedTech Consultants

Synergen MedTech is a boutique consultancy firm specializing in business development for the biotechnology and healthcare industry. With a dedicated focus on early-stage SME companies, we provide customized solutions and strategic guidance to drive growth and success. Our team of seasoned experts combines industry knowledge with a passion for innovation. We understand the unique challenges faced by healthcare startups, CEOs, Founders & executive teams and work closely with our clients to unlock their full potential.

From business development and market expansion to innovative marketing and sales strategies, grant writing, and global distribution advice, we offer a comprehensive range of services tailored to meet your specific needs. Our goal is to empower you to thrive in the dynamic world of bio & medical technology.

If you are ready to take your biotech and healthcare venture to new heights, let's connect and explore how we can collaborate. Visit our website at www.synergenmedtech.com or reach out to me directly at gary@synergenmedtech.com.

Under the auspices of Synergen I also serve as the CEO of Motion Informatics Ltd and CEO of MemoApp, a social impact enterprise.

CEO & Founder

GrayMatters Health

•	Devised a comprehensive go-to-market & reimbursement strategy for market entry in the USA and EU.
•	Implemented a growth strategy that increased market share and identified new revenue streams.
•	Spearheaded a product development team that launched an FDA-approved software product.
•	Identified and capitalized on opportunities to create future revenue streams.

Vice President Business Development, CMO and Product Management

Nanomedic Technologies

•	Secured private funding through effective financing and funding strategy, enabling company expansion, and accelerating product development.
•	Streamlined business process flows and improved sales productivity, reducing sales time by 15% and saving in S & M expenses.
•	Created a thorough plan for entering the USA and EU markets, including strategies for go-to-market and reimbursement.
•	Synthesized company and competitor performance data to identify and tap into untapped markets, resulting in a 25% increase in global sales within two years.
•	Created and executed digital marketing campaigns, resulting in a 300% increase in website traffic and a 50% increase in sales leads.
•	Implemented a balanced scorecard and sales and operations planning process across all business units, resulting in a 10% increase in overall business performance.

Vice President – Global Business Development, VP - Marketing & Sales, Chief Commercial Officer

HealthWatch Ltd.

•	Formulated and executed strategic initiatives to improve product offerings, leading to increased revenue and sales in first year sales of over $1M.
•	Managed global brand development, open innovation, and strategic alliances & partnerships, resulting in the acquisition of three new strategic partners.
•	Monitored industry trends, staying abreast of the latest changes and competition in the industry.
•	Directed investments in technology that supported sales productivity and worked closely with VP of R&D and Clinical to direct technology strategy, resulting in a 20% increase in sales productivity.
•	Managed global brand development, open innovation, and strategic alliances & partnerships.

Executive Vice President Business Development, VP - Marketing & Sales, Chief Commercial Officer

Ornim Medical

•	Managed global brand development, open innovation, and strategic alliances & partnerships, resulting in a 30% increase in international sales within three years.
•	Formulated a comprehensive strategy to penetrate the markets of the United States and European Union, which encompassed go-to-market and reimbursement strategies.
•	Led development of strategic marketing plans, resulting in increased sales growth in the USA, Asia, and EU.
•	Established and managed key strategic partnerships with major hospitals, universities, and physicians, resulting in $1M in new business opportunities.
•	Conducted extensive market research to identify unmet needs and create new product offerings.

Vice President Business Development, VP - Marketing & Sales, Chief Commercial Officer

P2W (Pollution to Water)

Vice President  Corporate Business Affairs

ITGI Medical

•	Executed development of strategic marketing plans, resulting in a 120% increase in sales growth in Asia and the EU.
•	Directed all activities related to regulation, reimbursement, and clinical trials, resulting in the successful approval of two new medical devices and $1M in new revenue streams.
•	Developed successful sales and marketing procedures using innovative strategies, resulting in a 150% YOY growth in revenue streams.
•	Developed and maintained relationships with strategic partners & customers.

Itamar Medical

•	Established, managed, recruited for, and directed the USA subsidiary, leading to $12 million in sales within three years despite no CPT code.
•	Developed and executed the reimbursement, FDA, & CME strategies.
•	Mentored and supported a high-performing team of 25 sales and marketing members, resulting in 150% YOY growth in revenue.
•	Mitigated regulatory risks by overseeing adherence to insurance and safety regulations.
•	Developed and implemented sales policies and procedures, resulting in 150% YOY growth in revenue.

Vice President- Global Business Development, VP - USA Subsidiary, VP - Marketing & Sales

I am an accomplished board-level senior manager and global business development specialist with extensive experience in digital, and analytical product industries, specializing in healthcare and medical devices. I excel in building effective penetration strategies for new markets and distributor networks, contributing to their growth and success, & building reimbursement strategies. My knowledge extends to AI, deep learning, SaaS software development and management, digital product development and management, neurology, cardiology, sleep medicine, trauma, and advanced wound care. My unique vision, creativity, and expertise consistently exceed revenue goals, establish new technology market leadership, and expand existing accounts. I have a proven track record of delivering exceptional results and driving sustainable growth in highly competitive medical marketplaces. As a dynamic leader, I develop top-performing sales teams and individuals within the global acute care sales market segment.

#Product Development Management #Global Business Development #Sales and Marketing #Strategic Planning #Market Research #Competitive Analysis #Digital Marketing #Brand Development #Innovation #Reimbursement #Risk Management #Business Process Improvement

Taplio

Gary J Sagiv's Linkedin Analytics

Want to drive more opportunities from LinkedIn?

Taplio

.css-1jgreyo{background-image:linear-gradient(284deg, rgba(39,43,72,1) 0%, rgba(33,47,183,1) 100%);color:transparent;-webkit-background-clip:text;background-clip:text;}Gary J Sagiv's Linkedin Analytics

Want to drive more opportunities from LinkedIn?

Gary J Sagiv's Linkedin Analytics